| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9467 |
| Human Intestinal Absorption | HIA+ | 0.9891 |
| Caco-2 Permeability | Caco2+ | 0.7762 |
| P-glycoprotein Substrate | Non-substrate | 0.8601 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9754 |
| Non-inhibitor | 0.9663 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8952 |
| Distribution |
| Subcellular localization | Lysosome | 0.4624 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8213 |
| CYP450 2D6 Substrate | Non-substrate | 0.8627 |
| CYP450 3A4 Substrate | Non-substrate | 0.7287 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.5116 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9354 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9634 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9398 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9526 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9263 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9740 |
| Non-inhibitor | 0.9777 |
| AMES Toxicity | Non AMES toxic | 0.9317 |
| Carcinogens | Non-carcinogens | 0.6362 |
| Fish Toxicity | High FHMT | 0.6304 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.8170 |
| Honey Bee Toxicity | Low HBT | 0.5547 |
| Biodegradation | Ready biodegradable | 0.7114 |
| Acute Oral Toxicity | III | 0.7701 |
| Carcinogenicity (Three-class) | Non-required | 0.5959 |